Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 35 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 9556244

    Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  2. US 9546368

    Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted
  3. US 9526882

    Percutaneous administration device and method for producing the same

    OPTNICS PRECISION CO., LTD. · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted
  4. US 9522137

    Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  5. US 9522910

    Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYOU “FUSION PHARMA” · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  6. US 9518262

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  7. US 9511212

    Implantable drug delivery device

    Nano Precision Medical, Inc. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  8. US 9506040

    Prevascularized constructs for implantation to provide blood perfusion

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  9. US 9506067

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  10. US 9498537

    Method of enhancing efficacy of blood transfusions

    The Regents of the University of California · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  11. US 9499606

    Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  12. US 9492520

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  13. US 9493626

    Dispersions comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  14. US 9493845

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    PTC THERAPEUTICS, INC. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  15. US 9491934

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  16. US 9486531

    Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system

    Indivior UK Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  17. US 9487786

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  18. US 9480669

    Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion

    The Regents of the University of California · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  19. US 9475871

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  20. US 9476051

    Antisense modulation of superoxide dismutase 1, soluble expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  21. US 9476052

    RNAi inhibition of alpha-ENaC expression

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  22. US 9447405

    Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

    The Regents of the University of California · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  23. US 9441225

    Compositions and methods for inhibiting expression of factor V

    Alnylam Pharmaceuticals, Inc. · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  24. US 9439948

    Degradable cage coated with mineral layers for spinal interbody fusion

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted